2023, Vol. 5, Issue 3, Part B

Background: Non-Alcoholic Fatty Liver Disease (NAFLD) has emerged as a significant public health concern, affecting a broad demographic spectrum. Among those impacted, the elderly population presents unique challenges and complexities in the diagnosis and management of this condition.

Objectives: This systematic review aims to assess the lab findings and Imaging evaluation of non- alcoholic fatty liver disease NAFLD in elderly.

Methods: A systematic search was conducted in electronic databases to identify eligible studies. For this review, Preferred Reporting Items guideline for conducting this systematic review analysis (PRISMA) was followed. Electronic articles from April 2023 to August 2023 were looked through on Bar Prescription, online Willey library, and Science Direct website. A deliberate and comprehensive hunt of electronic information bases like PubMed, Embase, Scopus, and the Cochrane Library was directed. The pursuit procedure was developed utilizing a blend of important watchwords and clinical subject headings.

Results: At first sight, the initial symptoms of selected studies were noted. A systematic search of electronic databases from April 2023 to August 2023 identified a total of 25 potentially relevant articles. After title and abstract screening, 5 articles were selected for full-text review. A total of 300 elderly patients (aged 65 and above) with non-alcoholic fatty liver disease (NAFLD) were included in the review. Comorbidities were prevalent, with 40% of patients having diabetes, 30% with hypertension, and 20% with dyslipidemia.

Conclusion: It is concluded that our systematic review provide essential role of laboratory findings in the diagnosis and management of NAFLD in the elderly and emphasizes the need for age-specific considerations in the assessment and care of this demographic. This review aims to contribute to enhanced clinical understanding and improved patient outcomes in the aging population with NAFLD.